You searched for "palsies"

552 results found

Haag-Streit UK announces appointment of Thomas Lenzen as new CEO

Haag-Streit UK is pleased to announce the appointment of Thomas Lenzen as the new Chief Executive Officer (CEO) of the Haag-Streit Group. Thomas Lenzen. With more than two decades of international leadership experience in the med tech industry, Thomas Lenzen...

Sustainability in eyecare: Intraocular gases and the climate emergency

In 2020 the NHS became the first national health system to commit to delivering ‘net zero’ carbon emissions by 2040. The author investigates how the impact of ophthalmic surgery can be reduced. Medical gases have been used in ophthalmic surgery...

A closer look at the new wave of glaucoma surgery – radical or old school?

Glaucoma is a challenging condition to treat because the exact pathophysiology remains unclear and the only readily modifiable factor is the intraocular pressure (IOP). Additionally, most glaucoma patients are completely asymptomatic, yet are often subjected to lifelong medical therapy. The...

Rare eye diseases: progress continues with authorised orphan medicines and breakthrough technologies

An update on the development of orphan medicines, recent regulatory treatment approvals for rare eye conditions and advances in retinal prosthetic technologies for blinding diseases. The prevalence of a rare disease is based usually on a range of estimates and...

Effective management of dry eye and ocular surface disease

Experts recommend a consistent approach to diagnosis, therapeutic targeting by disease subtype and escalation of therapy when tear substitutes are not sufficient. Experts call for a consistent, unified approach to diagnosis of dry eye disease (DED), with a new simple...

Eye News to host educational day focused on AI and new technology

We’re delighted to announce that we will be hosting a symposium again next year as part of Eyecare 2020.

CHEC and Royal National Institute for Blind People Launch Strategic Partnership

CHEC has today announced the launch of a new partnership with the Royal National Institute of Blind People.

Researchers identify a novel genetic cause of Fuchs endothelial corneal dystrophy

Researchers identify a novel genetic cause of Fuchs endothelial corneal dystrophy, offering new ways for future therapies to target this common, age-related cause of visual loss. In a landmark study, researchers supported by NIHR Moorfields Biomedical Research Centre, have identified...

Moorfields: Vitreoretinal emergencies: A practical guide for health care professionals

Vitreoretinal emergencies: A practical guide for health care professionals

Retinal pigment epithelium tears

In this paper the authors review the current knowledge of retinal pigment epithelium (RPE) tears. Although rare these can cause loss of visual acuity. They can occur spontaneously in pigment epithelial detachment (PED) due to occult choroidal neovascularisation (CNV), retinal...

Moorfields earns UK’s first UKAS accreditation for ophthalmic and vision science (IQIPS)

The United Kingdom Accreditation Service (UKAS) has granted the first accreditation for Ophthalmic and Vision Science to Moorfields Eye Hospital. The award was made to the Electrophysiology Department at Moorfields under the Improving Quality In Physical Services (IQIPS) programme.

Diagnosis and management of IV cranial nerve palsy

Aetiology: Trochlear nerve palsy can be divided into acute or congenital. Congenital trochlear nerve palsy is usually noted in childhood with development of abnormal head posture. Various pathologies can lead to acute IV nerve palsy, most commonly trauma. Other causes...